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ABSTRACT. Disturbances in blood flow to intervertebral discs (IVD) 
play an important role in IVD degeneration. Vascular endothelial 
growth factor (VEGF) and endothelial nitric oxide synthase (eNOS) 
are extremely important angiogenic factors for vasodilation and 
neovascularization. We investigated the relationship between single 
nucleotide polymorphisms (SNPs) of the VEGF and eNOS genes and 
genetic susceptibility to lumbar IVD degeneration in a young adult 
Korean population. Two hundred and forty-one participants (aged 
18 to 30 years), with or without low back pain, were selected for the 
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study. Magnetic resonance imaging was made of the lumbar spine in all 
participants. The patient group (N = 102) had low back pain clinically 
and lumbar IVD degeneration radiographically. The control group (N 
= 139) included subjects with and without low back pain; all were 
negative radiographically for lumbar IVD degeneration. Using PCR-
RFLP analysis, we analyzed VEGF (-2578C>A, -1154G>A, -634G>C, 
and 936C>T) and eNOS (-786T>C, 4a4b and 894G>T) SNPs. We made 
combined analyses of the genes and performed haplotype analyses. 
There were no significant differences in the genotype distribution of 
polymorphisms of VEGF and eNOS genes among patients and controls. 
However, the frequency of VEGF -2578CA +AA/-634CC combined 
genotypes was significantly higher in patients when compared with 
controls [odds ratio (OR) = 21.00; 95% confidence interval (CI) = 2.590-
170.240]. The frequencies of the -2578A/-1154A/-634C/936C (OR = 
3.831; 95%CI = 1.068-13.742), -2578A/-1154A/-634C (OR = 3.356; 
95%CI = 1.198-9.400), and -2578A/-634C/936C (OR = 10.820; 95%CI 
= 2.811-41.656) haplotypes were also significantly higher in patients 
than in controls. We conclude that the combined genotype VEGF 
-2578CA+AA/-634CC is a possible risk factor for IVD degeneration and 
the VEGF -2578A/-1154A/-634C/936C haplotype may increase the risk 
for development of IVD degeneration. Furthermore, the VEGF -634C 
allele appears to be associated with susceptibility to IVD degeneration.
Key words: Endothelial nitric oxide synthase; Polymorphism;
Intervertebral disc degeneration; Vascular endothelial growth factor
INTRODUCTION
The lumbar intervetebral disc (IVD) is the largest avascular tissue, and adequate nu-
tritional supply is critical for maintenance of a healthy IVD. This supply from the surrounding 
vasculature occurs mainly through diffusion from the vertebral endplates with a minor contri-
bution from the vessels surrounding the periphery of the annulus (Shi et al., 2011). Disc cells 
depend on the blood supply from the capillaries at their margins to supply nutrients and remove 
metabolic waste. Therefore, blood flow disturbance in the IVD has been proposed to play a 
role as a causative factor in the IVD degeneration (Nachemson et al., 1970; Buckwalter, 1995; 
Urban et al., 2004; Awata et al., 2005; Niinimäki et al., 2009; Shi et al., 2011). The lumbar IVD 
is mostly supplied by the capillaries of lumbar arteries feeding the vertebral endplates, and 
the blood supply can be disturbed by lumbar arteries narrowing due to atherosclerosis or by 
occlusion of endplate openings due to morphological changes (Kurunlahti et al., 1999, 2001; 
Benneker et al., 2005; Moore, 2006; Niinimäki et al., 2009; Kauppila, 2009; Wang and Griffith, 
2011). Thus, atherosclerosis and other cardiovascular risk factors have received growing atten-
tion as potential underlying factors for IVD degeneration (Kauppila and Tallroth, 1993; Kurun-
lahti et al., 1999; Kauppila et al., 2004; Leino-Arjas et al., 2008; Kauppila, 2009). Characteristic 
features of IVD degeneration include nuclear dehydration, proteoglycan loss, decreased cellu-
larity, disorganization, and annular disruption (Lotz, 2004). Another feature of IVD degenera-
tion is blood vessel ingrowth in the degenerated disc through the vertebral endplate or through 
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the annulus fibrosus (Brown et al., 1997; Freemont et al., 2002; Haro et al., 2002). Since athero-
sclerosis is associated with IVD degeneration and since angiogenesis occurs as a degenerative 
process of the IVD, it is reasonable to hypothesize that genes related to atherosclerosis and 
angiogenesis are candidates to determine the risk of developing IVD degeneration. Therefore, 
single nucleotide polymorphisms (SNPs) in genes previously implicated in angiogenesis or 
atherosclerosis may contribute to the etiology of IVD degeneration.
With regard to atherosclerosis and angiogenesis, vascular endothelial growth factor (VEGF) 
and nitric oxide (NO) are important. VEGF is a key mediator of angiogenesis, and NO is a regula-
tor of VEGF-mediated angiogenesis (La Rosa et al., 2003; Lin et al., 2010). VEGF induces NO 
production from vascular endothelial cells via endothelial NO synthase (eNOS; Fukumura et al., 
2001). Thus, SNPs of the VEGF and eNOS genes have been shown to be associated with the devel-
opment of atherosclerosis, coronary heart disease, and ischemic stroke (Lin et al., 2010; Song et al., 
2010; Kim et al., 2007, 2011). Our group investigated the effect of VEGF -2578C>A, -1154G>A, 
-634G>C, and 936C>T polymorphisms on susceptibility to ischemic stroke and also investigated 
an association of eNOS (-786T>C, 4a4b, and 894G>T) polymorphisms with silent brain infarction 
and coronary artery disease (Song et al., 2010; Kim et al., 2007, 2011). Until now, however, no pub-
lished studies explored the association of polymorphisms in VEGF and eNOS genes with genetic 
susceptibility to IVD degeneration. Therefore, we aimed to investigate whether SNPs in the VEGF 
and eNOS genes are associated with susceptibility to IVD degeneration in the Korean population.
MATERIAL AND METHODS
Study population
The case-control population comprised 241 adult unrelated Korean residents (age 18-30 
years) who were selected between 2009 and 2011. A total of 102 lumbar IVD degeneration cases 
(68 males, 34 females; mean age ± standard deviation, 23.6 ± 6.3 years) were recruited from CHA 
Bundang Medical Center. All patients had clinically evident low back pain and radiographically evi-
dent lumbar IVD degeneration (grade III or higher, according to the 5-grade classification system) 
(Pfirrmann et al., 2001). The control group consisted of 139 healthy volunteers (80 men, 59 women; 
23.4 ± 4.1 years) with no history of lumbar trauma or back problems. All controls were examined 
by MRI to exclude individuals with asymptomatic lumbar IVD degeneration. Lumbar spine MRI 
showed grade I or II discs according to the Pfirrmann grading system (Pfirrmann et al., 2001). None 
of the subjects were involved in heavy physical labor or were exposed to vibration at work, and 
all participants were non-smokers. We excluded subjects with history of stroke or ischemic heart 
disease, diagnosis with endocrine disorders such as hyperthyroidism, primary hyperparathyroidism, 
pituitary diseases, diabetes mellitus, liver disease, hypercholesterolemia, or renal disease. Patients 
receiving treatments with the potential to interfere with bone metabolism were also excluded, such 
as oral contraceptives, hormone replacement therapy, corticosteroids, calcium, or vitamin D. No 
subject was obese or had a body mass index >30 kg/m2.
The study was approved by the Institutional Review Board of CHA Bundang Medical 
Center, and written informed consent was obtained from all participants in this study.
Grading of IVD degeneration and severity score 
The lumbar spines of the participants were imaged with a 1.5-Tesla MRI unit (Signa® 
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HDxt 1.5T; GE Healthcare, Milwaukee, WI, USA). The presence of lumbar IVD degeneration 
was determined from T2-weighted sagittal images (2000-ms repetition time and 110-ms echo 
time). Two independent radiologists assessed the signal intensity of individual discs between the 
L2-L3 and L5-S1 level. The cerebrospinal fluid adjacent to the corresponding disc level was used 
as a reference for signal intensity. The grade of IVD degeneration was determined according to 
the Pfirrmann classification system (Pfirrmann et al., 2001). Grade I indicated homogeneous with 
a bright hyperintense signal intensity and a normal disc height; grade II, inhomogeneous with a 
hyperintense signal and a normal disc height; grade III, inhomogeneous with an intermediate gray 
signal intensity and a normal or slightly decreased disc height; grade IV, inhomogeneous with a 
hypointense gray signal and a normal or moderately decreased disc height; and grade V, inhomo-
geneous with a hypointense black signal intensity and a collapsed disc height. The presence of 
disc herniation was also evaluated. We included only patients with degenerative IVD grade III or 
higher and excluded patients with clearly herniated or extruded discs. The presence of multilevel 
IVD degeneration was assessed as the number of disc levels with the same degenerative change. A 
‘severity score’ was developed to grade the global degree of IVD degeneration within the lumbar 
spine, with this score determined on the basis of the numbers of degenerative discs between L2-
L3 and L5-S1 (e.g., 1 = one degenerated level).
Genotyping
Genomic DNA was extracted from peripheral blood leukocytes using the G-DEX blood 
extraction kit (iNtRON Biotechnology, Inc., Seongnam, South Korea). Four SNPs in the VEGF 
gene were studied, which included 2 promoter region SNPs (-2578C>A, rs699947 and -1154G>A, 
rs1570360), 1 leader sequence (-634G>C, rs2010963), and one 3ꞌ-untranslated region SNP (936C>T, 
rs3025039). All SNP sequences were obtained from the HapMap database (www.hapmap.org). 
Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) assay was per-
formed to analyze the VEGF -2578C>A and 936C>T polymorphisms. The VEGF -1154G>A and 
-634G>C polymorphisms were analyzed by real-time PCR. The primers and PCR conditions for the 
determination of VEGF SNP have been previously described (Del Bo et al., 2005). 
The 3 SNPs of the eNOS gene were selected, which included -786T>C, rs2070744; 
894G>T, rs1799983, and eNOS 4a4b [27-bp variable number of tandem repeat (VNTR) polymor-
phism in intron 4]. PCR-RFLP assay was performed to analyze these 3 SNPs. The primers and PCR 
conditions for the determination of eNOS SNP have been previously described (Inoue et al., 1998).
Statistical analysis 
Genotype frequencies were compared between cases and controls using the chi-square 
test and the Fisher exact test when appropriate, and odds ratios (OR) and 95% confidence in-
tervals (CI) were calculated to estimate the relative risk of IVD degeneration conferred by each 
polymorphism. Association of SNPs with the IVD degeneration was analyzed by multivariate 
logistic regression adjusted for possible confounders, including age and gender. Demographic 
data between groups were compared by the chi-square test for categorical variables such as gen-
der and by the Mann-Whitney test for quantitative variables such as age. The haplotypes were 
classified using the HAPSTAT 3.0 software (http://dlin.web.unc.edu/software/hapstat/), and as-
sociation between VEGF and eNOS polymorphisms and IVD degeneration was estimated by OR 
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and 95%CI. Statistical analyses were performed using the SPSS software (version 11.0; SPSS 
Inc., Chicago, IL, USA) and the StatsDirect Statistical Software (Version 2.4.4, StatsDirect Ltd., 
Altrincham, UK). The level of statistical significance was set at P < 0.05. 
RESULTS
There were no significant differences between cases and controls for mean age or gender 
distribution. Among the patients with the IVD degeneration, the disc degeneration severity score was 
analyzed according to the genotypes of VEGF and eNOS. No significant differences were observed 
in severity scores between the genotypes for each SNP in the VEGF and eNOS genes (Table 1). 
Therefore, we investigated the association between SNPs in VEGF and eNOS genes and patients 
with any severity score >1. A comparison of genotype and allele frequencies of the VEGF -2578C>A, 
-1154G>A, -634G>C, and 936C>T polymorphisms and eNOS-786T>C, intron 4, and 894G>T poly-
morphisms between case and control groups is shown in Table 2. Genotype distributions of each 
polymorphism did not deviate from those expected based on the Hardy-Weinberg equilibrium. The 
frequencies of VEGF -2578CA+AA (51.0%), -1154GA+AA (29.4%), -634GC+CC (74.5%), eNOS 
-786TC+CC (21.6%), and 894GT+TT (27.5%) were higher in the patients compared with controls. 
However, no statistically significant differences between patients and controls were found (Table 2).
 Number (%) Score (means ± SD) Pa
eNOS -786T>C
   TT 118 (84.9) 2.750 ± 1.268 Reference
   TC   21 (15.1) 2.571 ± 1.121 0.549 
   CC   0 (0.0) -  -
   TC+CC   21 (15.1) 2.545 ± 1.101 0.496 
eNOS 4a4b
   4b4b 115 (82.7) 2.750 ± 1.268 Reference
   4a4b   24 (17.3) 2.571 ± 1.121 0.549 
   4a4a   0 (0.0) -  -
   4a4b+4a4a   24 (17.3) 2.545 ± 1.101 0.496 
eNOS 894G>T
   GG 111 (79.9) 2.813 ± 1.193 Reference
   GT   25 (18.0) 2.455 ± 1.335 0.256 
   TT   3 (2.1) 2.200 ± 1.304 0.288 
   GT+TT   28 (20.1) 2.407 ± 1.309 0.158 
VEGF -2578C>A
   CC   75 (54.0) 2.800 ± 1.161 Reference
   CA   55 (39.5) 2.707 ± 1.309 0.816 
   AA   9 (6.5) 2.273 ± 1.272 0.215 
   CA+AA   64 (46.0) 2.615 ± 1.301 0.520 
VEGF -1154G>A
   GG 102 (73.4) 2.625 ± 1.238 Reference
   GA   28 (20.1) 3.000 ± 1.243 0.206 
   AA   9 (6.5) 2.571 ± 1.134 0.945 
   GA+AA   37 (26.6) 2.900 ± 1.213 0.300 
VEGF -634G>C
   GG   48 (34.5) 2.885 ± 1.211 Reference
   GC   64 (46.0) 2.692 ± 1.213 0.553 
   CC   27 (19.5) 2.542 ± 1.318 0.374 
   GC+CC   91 (65.5) 2.645 ± 1.240 0.432 
VEGF 936C>T
   CC   95 (68.3) 2.821 ± 1.235 Reference
   CT   38 (27.4) 2.348 ± 1.191 0.124 
   TT   6 (4.3) 2.000  -
   CT+TT   44 (31.7) 2.333 ± 1.167 0.108
Table 1. Severity score levels of eNOS and VEGF polymorphisms in patients with disc degeneration.
eNOS = endothelial nitric oxide synthase; VEGF = vascular endothelial growth factor; SD = standard deviation. 
aCalculated by the Mann-Whitney U-test.
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Genotypes Control (%) Case (%) OR (95%CI) P
eNOS -786T>C
   TT 118 (84.9) 80 (78.4) 1.000 
   TC   21 (15.1) 21 (20.6) 1.475 (0.756-2.878) 0.253 
   CC   0 (0.0) 1 (1.0)     4.416 (0.178-109.856) 0.407
   TC+CC   21 (15.1) 22 (21.6) 1.545 (0.797-2.996) 0.196 
eNOS 4a4b
   4b4b 115 (82.7) 80 (78.4) 1.000
   4a4b   24 (17.3) 21 (20.6) 1.258 (0.656-2.413) 0.490 
   4a4a   0 (0.0) 1 (1.0)     4.304 (0.173-107.088) 0.413
   4a4b+4a4a   24 (17.3) 22 (21.6) 1.318 (0.691-2.512) 0.401 
eNOS 894G>T
   GG 111 (79.9) 74 (72.5) 1.000 
   GT   25 (18.0) 23 (22.6) 1.380 (0.729-2.613) 0.322 
   TT   3 (2.1) 5 (4.9)   2.500 (0.580-10.782) 0.276 
   GT+TT   28 (20.1) 28 (27.5) 1.500 (0.823-2.736) 0.185 
VEGF -2578C>A
   CC   75 (54.0) 50 (49.0) 1.000 
   CA   55 (39.5) 41 (40.2) 1.118 (0.652-1.919) 0.685 
   AA   9 (6.5) 11 (10.8) 1.833 (0.708-4.746) 0.207 
   CA+AA   64 (46.0) 52 (51.0) 1.219 (0.730-2.034) 0.449 
VEGF -1154G>A
   GG 102 (73.4) 72 (70.6) 1.000 
   GA   28 (20.1) 23 (22.5) 1.164 (0.621-2.182) 0.636 
   AA   9 (6.5) 7 (6.9) 1.102 (0.392-3.096) 0.854 
   GA+AA   37 (26.6) 30 (29.4) 1.149 (0.651-2.028) 0.633 
VEGF -634G>C
   GG   48 (34.5) 26 (25.5) 1.000 
   GC   64 (46.0) 52 (51.0) 1.500 (0.822-2.737) 0.185 
   CC   27 (19.5) 24 (23.5) 1.641 (0.792-3.399) 0.181 
   GC+CC   91 (65.5) 76 (74.5) 1.542 (0.875-2.716) 0.133 
VEGF 936C>T
   CC   95 (68.3) 78 (76.5) 1.000 
   CT   38 (27.4) 23 (22.5) 0.737 (0.405-1.341) 0.317 
   TT   6 (4.3) 1 (1.0) 0.203 (0.024-1.723) 0.137
   CT+TT   44 (31.7) 24 (23.5) 0.664 (0.372-1.187) 0.166
Table 2. Comparison of genotype frequencies of eNOS and VEGF polymorphisms between the patients and 
control subjects.
OR = odds ratio; CI = confidence interval. P values were adjusted for age and gender. For other abbreviations, see 
legend to Table 1.
The linkage disequilibrium (LD) for SNPs in the VEGF and eNOS genes in pa-
tients is shown in Figure 1. D prime (Dꞌ) and the square of the correlation coefficient 
(r2) were calculated to assess the level of LD between each SNP. There was strong LD 
between eNOS -786 and 4a4b (Dꞌ = 0.975, r2 = 0.883) in patients (Figure 1A). Polymor-
phisms VEGF -2578C>A and -1154G>A were in moderate level of LD (Dꞌ = 0.732, r2 = 
0.284) in patients (Figure 1B).
The combination analysis of VEGF and eNOS gene polymorphisms is shown in 
Tables 3 and 4. The frequencies of VEGF -2578CA+AA/-634CC combined genotypes were 
significantly higher in patients with lumbar IVD degeneration compared with controls (OR 
= 21.000; 95%CI = 2.590-170.240; P = 0.000) (Table 3). The frequencies of eNOS com-
bined genotypes were not statistically different between case and control groups (Table 4).
We constructed separate haplotypes with 4 VEGF and 3 eNOS polymorphisms 
to determine whether any specific haplotypes were associated with IVD degeneration 
(Tables 5 and 6). The frequencies of the A-A-C-C (VEGF -2578/-1154/-634/936; OR = 
3.831; 95%CI = 1.068-13.742; P = 0.002), A-A-C (VEGF -2578/-1154/-634; OR = 3.356; 
95%CI = 1.198-9.400; P = 0.001), and A-C-C (VEGF -2578/-634/-936; OR = 10.820; 
95%CI = 2.811-41.656; P < 0.0001) haplotypes were also significantly higher in patients 
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BA
Figure 1. A. Linkage disequilibrium (LD) analysis of single nucleotide polymorphisms (SNPs) [-786 (rs2070744), 
27-bp VNTR, and +894 (rs1799983)] in the eNOS gene. Values in squares are LD between single markers. B. LD 
analysis of SNPs [-2578 (rs699947), -1154 (rs1570360), -634 (rs2010963), and +936 (rs3025039)] in the VEGF gene.
Genotypes Control (%) Case (%) OR (95%CI) P
VEGF -2578C>A /-1154G>A
   CC/GG   74 (53.2) 45 (44.1) 1.000
   CC/GA+AA   1 (0.7) 5 (4.9)   8.222 (0.930-72.686) 0.037
   CA+AA/GG   28 (20.1) 27 (26.5) 1.586 (0.831-3.025) 0.160
   CA+AA/GA+AA   36 (25.9) 25 (24.5) 1.142 (0.608-2.146) 0.680
VEGF -2578C>A /-634G>C
   CC/GG+GC   49 (35.3) 38 (37.3) 1.000
   CC/CC   26 (18.7) 12 (11.8) 0.808 (0.353-1.847) 0.612
   CA+AA/GC+CC   63 (45.3) 40 (39.2) 1.111 (0.603-2.046) 0.735
   CA+AA/CC   1 (0.7) 12 (11.8)   21.000 (2.590-170.240) 0.000
VEGF -2578C>A /936C>T
   CC/CC   54 (38.8) 39 (38.2) 1.000
   CC/CT+TT   21 (15.1) 11 (10.8) 0.725 (0.314-1.677) 0.451
   CA+AA/CC   41 (29.5) 39 (38.2) 1.317 (0.722-2.404) 0.369
   CA+AA/CT+TT   23 (16.5) 13 (12.7) 0.783 (0.353-1.734) 0.545
VEGF -1154G>A /-634G>C
   GG/GG+GC   76 (54.7) 52 (51.0) 1.000
   GG/CC   26 (18.7) 20 (19.6) 1.124 (0.569-2.223) 0.736
   GA+AA/GG+GC   36 (25.9) 26 (25.5) 1.056 (0.570-1.954) 0.863
   GA+AA/CC   1 (0.7) 4 (3.9)   5.846 (0.635-53.831) 0.161
VEGF -1154G>A /936C>T
   GG/CC   72 (51.8) 57 (55.9) 1.000
   GG/CT+TT   30 (21.6) 15 (14.7) 0.632 (0.310-1.286) 0.203
   GA+AA/CC   23 (16.5) 21 (20.6) 1.153 (0.581-2.291) 0.684
   GA+AA/CT+TT   14 (10.1) 9 (8.8) 0.812 (0.328-2.011) 0.652
VEGF -634G>C / 936C>T
   GG+GC/CC   78 (56.1) 63 (61.8) 1.000
   GG+GC/CT+TT   34 (24.5) 15 (14.7) 0.546 (0.273-1.092) 0.085
   CC/CC   17 (12.2) 15 (14.7) 1.092 (0.506-2.359) 0.822
   CC/CT+TT 10 (7.2) 9 (8.8) 1.114 (0.427-2.910) 0.825
Table 3. Combination analysis of VEGF polymorphisms in patients and controls.
P values were adjusted for age and gender. For abbreviations, see legends to Tables 1 and 2.
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Genotypes Control (%) Case (%) OR (95%CI) P
eNOS -786T>C/4a4b
   TT/4b4b 115 (82.7) 79 (77.4) 1.000 
   TT/4a4b   3 (2.2) 1 (1.0) 0.485 (0.050-4.752)   0.649
   TC/4b4b   0 (0.0) 1 (1.0)     4.359 (0.175-108.446)   0.410
   TC/4a4b   21 (15.1) 20 (19.6) 1.386 (0.705-2.726)   0.342 
   CC/4a4a   0 (0.0) 1 (1.0)     4.359 (0.175-108.446)   0.410
eNOS -786T>C/894G>T
   TT/GG   90 (64.7) 54 (52.9) 1.000
   TT/GT   25 (18.0) 21 (20.6) 1.400 (0.716-2.739)   0.325 
   TT/TT   3 (2.2) 5 (4.9)   2.778 (0.638-12.093)   0.262
   TC/GG   21 (15.1) 20 (19.6) 1.587 (0.789-3.194)   0.193 
   TC/GT   0 (0.0) 1 (1.0)     4.982 (0.199-124.557)   0.379
   CC/GG   0 (0.0) 1 (1.0)     4.982 (0.199-124.557)   0.379
eNOS 4a4b/894G>T
   4b4b/GG   87 (62.5) 53 (51.9) 1.000 
   4b4b/GT   25 (18.0) 22 (21.6) 1.445 (0.741-2.815)   0.279 
   4b4b/TT   3 (2.2) 5 (4.9)   2.736 (0.628-11.921)   0.263
   4a4b/GG   24 (17.3) 21 (20.6) 1.436 (0.729-2.830)   0.294 
   4a4a/GG   0 (0.0) 1 (1.0)     4.907 (0.196-122.732)   0.383
eNOS -786T>C/4a4b/894G>T
   TT/4b4b/GG   87 (62.5) 53 (51.9) 1.000 
   TT/4b4b/GT   25 (18.0) 21 (20.6) 1.379 (0.703-2.704)   0.349 
   TT/4b4b/TT   3 (2.2) 5 (4.9)   2.736 (0.628-11.921)   0.263
   TT/4a4b/GG   3 (2.2) 1 (1.0) 0.547 (0.055-5.400)   1.000
   TC/4b4b/GT   0 (0.0) 1 (1.0)     4.907 (0.196-122.732) 0.38
   TC/4a4b/GG   21 (15.1) 20 (19.6) 1.563 (0.775-3.152)   0.210 
   CC/4a4a/GG   0 (0.0) 1 (1.0)     4.907 (0.196-122.732)   0.383
Table 4. Combination analysis of eNOS polymorphisms in patients and control subjects.
P values were adjusted for age and gender. For abbreviations, see legends to Tables 1 and 2.
than in controls (Table 5). There were no significant differences between patient and con-
trol groups for haplotypes constructed from eNOS SNP (Table 6).
DISCUSSION
We conducted a case-control study to investigate the relationship between SNPs of the 
VEGF and eNOS genes, their haplotypes, and IVD degeneration in a young Korean population. The 
data suggested that the combined genotypes of VEGF -2578CA+AA/-634CC were significantly as-
sociated with IVD degeneration. In addition, -2578A/-1154A/-634C/936C, -2578A/-1154G/-634C, 
and -2578A/-634C/936C haplotypes were associated with increased risk of IVD degeneration, 
whereas -2578A/-1154A/-634G and -2578A/-1154G/-634G were protective against IVD degenera-
tion. The VEGF haplotypes associated with high risk of IVD degeneration contain the -634C allele. 
Thus, the VEGF -634C allele may be important for susceptibility to IVD degeneration.
The effects of polymorphisms in the VEGF gene are likely to be manifested as dif-
ferential expression of VEGF protein between individuals and may be linked to a difference in 
susceptibility to IVD degeneration. Clinical studies have shown that the VEGF SNP -2578A and 
-1154A alleles decrease VEGF expression, but VEGF -634G>C SNP has been correlated with 
a weak ability for VEGF production (Watson et al., 2000; Awata et al., 2002; Niinimäki et al., 
2009). Awata et al. (2005) proposed that the VEGF -634C allele is associated with increased 
transcription levels of VEGF, whereas Lambrechts et al. (2005) reported that VEGF -634G is 
associated with lower VEGF expression. However, our study was limited in this respect, since 
we did not measure VEGF levels to show the association between them and the development of 
IVD degeneration.
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Table 5. Haplotype analysis of VEGF polymorphisms in patients and controls.
P values were adjusted for age and gender. For abbreviations, see legends to Tables 1 and 2.
Haplotypes Control (%) Case (%) P OR (95%CI)
VEGF -2578C>A /-1154G>A/-634G>C/936C>T
   C-G-C-C 34.2 25.3 0.036  0.842 (0.722-0.982)
   C-G-G-C 26.0 32.1 0.116  1.150 (0.959-1.379)
   A-A-G-C   9.5   5.4 0.084  0.797 (0.641-0.992)
   A-G-G-C   9.3   4.8 0.068  0.784 (0.630-0.975)
   C-G-C-T   7.2   4.3 0.208  0.827 (0.640-1.070)
   C-G-G-T   4.0   2.6 0.366  0.835 (0.594-1.172)
   A-A-G-T   3.7   1.2 0.069  0.685 (0.526-0.893)
   A-G-G-T   2.8   0.0 0.015  0.571 (0.528-0.617)
   C-A-G-C   2.4   4.1 0.377  1.245 (0.721-2.151)
   A-A-C-C   0.7   5.6 0.002    3.831 (1.068-13.742)
   A-A-C-T   0.3   1.2 0.390  1.738 (0.350-8.628)
   A-G-C-C   0.0 10.4 <0.0001 -
   A-G-C-T   0.0   2.3 0.009  -
   C-A-G-T   0.0   0.7 0.242  -
VEGF -2578C>A/-1154G>A/-634G>C
   C-G-C 41.5 29.5 0.006  0.806 (0.694-0.936)
   A-A-G 13.2   6.6 0.014  0.755 (0.628-0.908)
   A-G-G 12.1   4.7 0.006  0.722 (0.603-0.865)
   A-A-C   1.0   6.7 0.001  3.356 (1.198-9.400)
   A-G-C   0.0 12.9 <0.0001 
VEGF -2578C>A /-1154G>A/936C>T
   C-G-T 11.2   7.1 0.165  0.842 (0.678-1.046)
   A-G-C   9.4 14.9 0.068  1.276 (0.953-1.709)
VEGF -2578C>A/-634G>C/936C>T
   C-C-C 34.1 25.2 0.032  0.839 (0.720-0.979)
   C-G-C 28.4 36.2 0.063  1.174 (0.984-1.400)
   A-G-C 18.8 10.4 0.009  0.772 (0.652-0.913)
   A-G-T   6.4   1.0 0.003  0.626 (0.530-0.740)
   A-C-C   0.7 16.0 <0.0001 10.820 (2.811-41.656)
   A-C-T   0.3   3.6 0.009    4.682 (0.747-29.346)
VEGF -1154G>A/-634G>C/936C>T
   G-G-T   7.0   3.0 0.042  0.737 (0.588-0.923)
   A-C-C   0.0   4.2 0.000  -
Atherosclerosis has been found to be associated with IVD degeneration, and angio-
genesis has been shown to be part of the degenerative process of IVD. However, it remains 
uncertain whether VEGF enhances or prevents IVD degeneration. Increased VEGF expres-
sion has been associated with the progress of atherosclerosis through neovascularization and 
inflammation in atheromatous plaques (Inoue et al., 1998; Celletti et al., 2001). Some studies 
have shown that expression of VEGF and nerve growth factor are significantly higher in de-
generative disc with no herniation compared with herniated disc, and angiogenesis is related 
to the presence of nerve fiber ingrowth into degenerative IVD and the appearance of disco-
genic low back pain (Freemont et al., 1997, 2002). Additionally, VEGF has been suggested to 
promote ectopic calcification via increase in angiogenesis (Karamouzian et al., 2010). Thus, 
we can infer that increased VEGF expression may aggravate IVD degeneration through the 
progress of atherosclerosis or calcification leading to occlusion of endplate openings, and 
further exacerbate low back pain by inducing nociceptive nerve ingrowth into degenerated 
disc. Conversely, others suggest that the VEGF is protective against IVD degeneration via the 
neovascularization of the degenerative disc (Haro et al., 2002; Kato et al., 2004; Walsh, 2004). 
Angiogenesis may be regarded as a part of the repair response (Haro et al., 2002). VEGF may 
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play a role in the resorption of the herniated disc, and the tendency of the herniated disc to 
spontaneous resorption is directly proportional to the degree of neovascularization (Haro et 
al., 2002). VEGF-induced neovascularization may explain why the symptoms of sciatic pain 
gradually improve without surgical treatment in some patients with herniated discs (Haro et 
al., 2002; Zhao et al., 2009). These previous theories and data support a strong relationship 
between the IVD and VEGF.
Haplotypes Control (%) Case (%) P OR (95%CI)
eNOS -786T>C/4a4b/894G>T
   T-4b-G 80.2 73.0 0.064  0.834 (0.680-1.023)
   T-4b-T 11.1 15.3 0.190  1.176 (0.906-1.528)
   C-4a-G   7.6 10.7 0.219  1.199 (0.874-1.644)
   T-4a-G   1.1   0.5 0.481  0.767 (0.433-1.358)
   C-4b-T   0.0   0.5 0.243  -
eNOS -786T>C/4a4b
   T-4b 91.3 88.3 0.257  0.854 (0.637-1.146)
   C-4a   7.6 10.7 0.219  1.199 (0.874-1.644)
   T-4a   1.1   0.5 0.481  0.767 (0.433-1.358)
   C-4b   0.0   0.5 0.243  -
eNOS -786T>C/894G>T
   T-G 81.2 73.9 0.056  0.826 (0.670-1.019)
   T-T 11.2 15.7 0.145  1.198 (0.921-1.559)
   C-G   7.6 10.4 0.292  1.168 (0.855-1.597)
eNOS 4a4b/894G>T
   4b-G 80.2 73.0 0.064  0.834 (0.680-1.023)
   4b-T 11.2 15.7 0.145  1.198 (0.921-1.559)
   4a-G   8.6 11.3 0.334  1.143 (0.855-1.530) 
Table 6. Haplotype analysis of eNOS polymorphisms in patients and controls.
P values were adjusted for age and gender. For abbreviations, see legends to Tables 1 and 2.
Because age has been shown to correlate with the IVD degeneration, we selected 
subjects from a restricted age range in an attempt to lessen the effect of this variable. Since 
young lumbar discs are exposed to environmental strain for less time than older discs, it is 
possible that genetic factors may have a specific role in the IVD degeneration in the younger 
population. In addition, IVD pathology (degeneration, bulging, protrusion, and extrusion) is a 
spectrum of disease and expression of VEGF could differ according to the stages of IVD pa-
thology. The increase in VEGF expression has been shown to have more severe low back pain 
in the IVD degeneration compared with herniated disc (Lee et al., 2009). We can recognize 
asymptomatic individuals with IVD degeneration. Thus, VEGF polymorphisms could be vari-
able according to age, stages of IVD pathology, and presence of low back pain. To minimize 
these possible confounders, we chose young subjects and excluded the patients with obvious 
disc protrusion or extrusion. On the basis of our results, we speculated that combined geno-
types of VEGF -2578CA+AA may be associated with insufficient blood supply to the IVD via 
narrowing of capillaries at the disc margins of the discs or change in endplate quality due to 
calcification.
There are several limitations in this study. 1) This was a hospital-based case-control study, 
which had a relatively small sample size and had no replication study. 2) The population studied 
comprised only Korean individuals, and because of interethnic variability in SNP and haplotype 
frequency, our findings will need to be validated in other ethnic groups. 3) Comparison between 
the IVD degeneration group and herniated disc group are required. 4) Imaging of lumbar arteries 
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is necessary to compare the degree of atherosclerosis between case and control groups. 5) Our 
results may underestimate the true impact of individual risk factors or other genetic factors. There-
fore, large-scale and replication studies are necessary to confirm and expand upon our findings. 
CONCLUSION
The proposed individual VEGF and eNOS polymorphisms were not associated with 
the risk of IVD degeneration. However, the frequency of the combined VEGF genotypes of 
-2578CA/-634CC and -2578AA/-634CC were significantly increased in patients with IVD de-
generation, suggesting that VEGF -2578CA/-634CC and -2578AA/-634CC could be genetic 
markers for IVD degeneration. In addition, the frequencies of the A-A-C-C (VEGF -2578/
-1154/-634/936), A-A-C (VEGF -2578/-1154/-634), A-C-C (VEGF -2578/-634/-936), and A-
C-T (VEGF -2578/-634/-936) haplotypes were significantly higher in patients than in controls, 
indicating that the VEGF -634C allele conferred risk for IVD degeneration. Our study is the 
first to investigate the relationship between VEGF and eNOS gene polymorphisms and IVD 
degeneration, and it provides important preliminary data to guide future investigations of these 
polymorphisms in a very common condition.
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